Literature DB >> 33547171

Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production.

Yulia Kushnareva1, Ian T Mathews1,2,3, Alexander Y Andreyev2,4, Gokmen Altay1, Cecilia S Lindestam Arlehamn1, Vijayanand Pandurangan1, Roland Nilsson5, Mohit Jain2,3, Alessandro Sette1,3, Bjoern Peters1,3, Sonia Sharma6.   

Abstract

CCR6+CXCR3+CCR4-CD4+ memory T cells, termed Th1*, are important for long-term immunity to Mycobacterium tuberculosis and the pathogenesis of autoimmune diseases. Th1* cells express a unique set of lineage-specific transcription factors characteristic of both Th1 and Th17 cells and display distinct gene expression profiles compared with other CD4+ T cell subsets. To examine molecules and signaling pathways important for the effector function of Th1* cells, we performed loss-of-function screening of genes selectively enriched in the Th1* subset. The genetic screen yielded candidates whose depletion significantly impaired TCR-induced IFN-γ production. These included genes previously linked to IFN-γ or M. tuberculosis susceptibility and novel candidates, such as ISOC1, encoding a metabolic enzyme of unknown function in mammalian cells. ISOC1-depleted T cells, which produced less IFN-γ and IL-17, displayed defects in oxidative phosphorylation and glycolysis and impairment of pyrimidine metabolic pathway. Supplementation with extracellular pyrimidines rescued both bioenergetics and IFN-γ production in ISOC1-deficient T cells, indicating that pyrimidine metabolism is a key driver of effector functions in CD4+ T cells and Th1* cells. Results provide new insights into the immune-stimulatory function of ISOC1 as well as the particular metabolic requirements of human memory T cells, providing a novel resource for understanding long-term T cell-driven responses.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33547171      PMCID: PMC7946769          DOI: 10.4049/jimmunol.2000672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Authors:  Tom H M Ottenhoff; Frank A W Verreck; Elgin G R Lichtenauer-Kaligis; Marieke A Hoeve; Ozden Sanal; Jaap T van Dissel
Journal:  Nat Genet       Date:  2002-09       Impact factor: 38.330

2.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.

Authors:  Guifang Cai; Anukanth Anumanthan; Julia A Brown; Edward A Greenfield; Baogong Zhu; Gordon J Freeman
Journal:  Nat Immunol       Date:  2008-01-13       Impact factor: 25.606

Review 3.  Heterogeneity of Human CD4(+) T Cells Against Microbes.

Authors:  Federica Sallusto
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

4.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.

Authors:  Benjamin J Schmiedel; Divya Singh; Ariel Madrigal; Alan G Valdovino-Gonzalez; Brandie M White; Jose Zapardiel-Gonzalo; Brendan Ha; Gokmen Altay; Jason A Greenbaum; Graham McVicker; Grégory Seumois; Anjana Rao; Mitchell Kronenberg; Bjoern Peters; Pandurangan Vijayanand
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

Review 5.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression.

Authors:  Maria Nikolova; Anne Marie-Cardine; Laurence Boumsell; Armand Bensussan
Journal:  Int Immunol       Date:  2002-05       Impact factor: 4.823

Review 7.  Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis.

Authors:  Shunsuke Sakai; Katrin D Mayer-Barber; Daniel L Barber
Journal:  Curr Opin Immunol       Date:  2014-08       Impact factor: 7.486

8.  Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation.

Authors:  Petya Dimitrova; Alla Skapenko; Matthias L Herrmann; Rudolf Schleyerbach; Joachim R Kalden; Hendrik Schulze-Koops
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

9.  Metabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation.

Authors:  Nicholas Jones; James G Cronin; Garry Dolton; Silvia Panetti; Andrea J Schauenburg; Sarah A E Galloway; Andrew K Sewell; David K Cole; Catherine A Thornton; Nigel J Francis
Journal:  Front Immunol       Date:  2017-11-09       Impact factor: 7.561

10.  Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro.

Authors:  Li Cheng; Yan Zhao; Maochun Tang; Zhengsheng Luo; Xingpeng Wang
Journal:  Oncol Lett       Date:  2019-02-28       Impact factor: 2.967

View more
  1 in total

1.  Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development.

Authors:  Jinghan Shi; Fujun Yang; Nanfeng Zhou; Yan Jiang; Yanfeng Zhao; Junjie Zhu; Arsela Prelaj; Jyoti Malhotra; Nicola Normanno; Elisa Danese; Andrés F Cardona; Xuan Hong; Gening Jiang; Xiao Song
Journal:  Transl Lung Cancer Res       Date:  2021-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.